Related Experiment Videos
Lymphocyte tubular structures in rheumatoid arthritis
Journal of Clinical Pathology
|September 1, 1977
Summary
Tubulo-reticular structures in lymphocytes were observed in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) patients, but not healthy individuals. Their presence in RA was linked to specific antibodies and treatments, not disease activity.
Area of Science:
- Electron microscopy
- Immunology
- Rheumatology
Background:
- Lymphocyte tubular structures are cellular inclusions observed in various conditions.
- Tubulo-reticular structures (TRS) and parallel tubular arrays (PTA) are distinct types of lymphocyte inclusions.
- Understanding the prevalence and associations of these structures can provide insights into autoimmune diseases.
Purpose of the Study:
- To investigate the presence and characteristics of lymphocyte tubular structures in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).
- To compare the occurrence of TRS and PTA in RA, SLE, and healthy controls.
- To identify potential associations between TRS and clinical/laboratory parameters in RA patients.
Main Methods:
- Electron microscopy was used to examine lymphocyte samples.
- Eighty patients with RA, 15 with SLE, and 10 healthy individuals were included.
- Presence and cellular density of TRS and PTA were quantified.
Main Results:
- TRS were detected in 13/80 RA patients and 10/15 SLE patients, but not in healthy controls.
- In RA patients, TRS presence was significantly associated with antinuclear antibodies, LE cell phenomenon, and chlorambucil treatment, but not disease activity.
- The average number of cells with TRS was lower in RA patients compared to SLE patients.
- PTA were found in all RA, SLE, and healthy individuals, with similar cellular prevalence across groups.
Conclusions:
- TRS are specific to certain autoimmune conditions like RA and SLE, unlike PTA which are commonly found.
- TRS in RA are associated with specific serological markers and treatments, suggesting a link to immune dysregulation beyond general disease activity.
- The lower prevalence of TRS in RA compared to SLE warrants further investigation into the distinct pathobiology of these conditions.